A detailed history of Lisanti Capital Growth, LLC transactions in Vericel Corp stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 114,990 shares of VCEL stock, worth $4.97 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
114,990
Previous 116,230 1.07%
Holding current value
$4.97 Million
Previous $6.05 Million 12.75%
% of portfolio
1.38%
Previous 1.59%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$41.71 - $52.9 $51,720 - $65,596
-1,240 Reduced 1.07%
114,990 $5.28 Million
Q1 2024

May 06, 2024

BUY
$32.52 - $52.33 $466,174 - $750,150
14,335 Added 14.07%
116,230 $6.05 Million
Q4 2023

Feb 06, 2024

SELL
$30.85 - $37.09 $653,865 - $786,122
-21,195 Reduced 17.22%
101,895 $3.63 Million
Q3 2023

Nov 02, 2023

SELL
$31.69 - $39.25 $1.57 Million - $1.95 Million
-49,675 Reduced 28.75%
123,090 $4.13 Million
Q2 2023

Aug 11, 2023

BUY
$29.0 - $38.37 $849,555 - $1.12 Million
29,295 Added 20.42%
172,765 $6.49 Million
Q1 2023

May 05, 2023

BUY
$23.85 - $31.34 $3.42 Million - $4.5 Million
143,470 New
143,470 $4.21 Million
Q3 2022

Nov 01, 2022

SELL
$22.62 - $32.54 $1.57 Million - $2.25 Million
-69,205 Reduced 51.32%
65,652 $1.52 Million
Q2 2022

Aug 03, 2022

BUY
$22.88 - $39.45 $39,856 - $68,721
1,742 Added 1.31%
134,857 $3.4 Million
Q1 2022

May 12, 2022

BUY
$31.69 - $43.29 $4.22 Million - $5.76 Million
133,115 New
133,115 $5.09 Million
Q4 2021

Feb 04, 2022

SELL
$35.2 - $52.6 $1.63 Million - $2.43 Million
-46,185 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
$46.35 - $59.75 $586,095 - $755,538
-12,645 Reduced 21.49%
46,185 $2.25 Million
Q2 2021

Aug 16, 2021

SELL
$47.2 - $67.81 $6.83 Million - $9.81 Million
-144,715 Reduced 71.1%
58,830 $3.09 Million
Q1 2021

May 12, 2021

BUY
$30.93 - $59.48 $2.81 Million - $5.4 Million
90,800 Added 80.54%
203,545 $11.3 Million
Q4 2020

Feb 10, 2021

BUY
$18.53 - $31.5 $2.09 Million - $3.55 Million
112,745 New
112,745 $3.48 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.04B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.